Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Atomwise Strengthens its Management Team, Adds Veteran Biopharma Leader David Thomson, Ph.D. as Chief Scientific Officer and Two Additional Senior Appointments
Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, announced today […]
H.E.L Group Appoints Rajeev Kumria as General Manager of H.E.L India
H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, […]
Amniotics Strengthens its Clinical and Regulatory Capabilities
Amniotics AB (publ) (Nasdaq Stockholm: AMNI), a developer of novel cell therapy products, has appointed […]
TFS HealthScience Appoints Eva Brike as Chief People Officer
TFS HealthScience, a global mid-size CRO, announced that Eva Brike has joined the company as […]
Nym Health Names Or Peles Senior Vice President of Research & Development
Nym Health, a leader in autonomous medical coding, today announced that Or Peles has joined […]
EmpiRx Health Appoints Nada Nicholas as Senior Vice President of Business Development for Labor
EmpiRx Health, the industry’s only value-based pharmacy benefit manager (PBM), today announced it has appointed Nada […]
Seekyo Reinforces Scientific Advisory Board with Two New Members
Seekyo, a startup company specializing in developing smart chemotherapy drugs, today announces the appointment of two […]
Ryvu Therapeutics Appoints Hendrik Nogai, M.D. as Chief Medical Officer
Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule […]
Aristea Therapeutics Announces Key Leadership Appointments to Advance its Clinical Pipeline
Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing novel therapies to treat […]
Arcensus has Appointed Prof. Dr. Arndt Rolfs as New CEO
Arcensus, a commercial-stage digital healthcare and diagnostics company that empowers people to take control of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more